In support of the heightened expression of IL33 and its receptor in primary ALL samples, we found that the exogenous addition of IL-33 increased cell viability and decreased apoptotic level as compared with untreated cells. This evidence concerns the gene IL33 and acute lymphoblastic leukemia.